本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

22.18
+0.01500.07%
成交量:65.14万
成交额:1,455.39万
市值:22.93亿
市盈率:-6.50
高:22.59
开:22.20
低:21.75
收:22.16
52周最高:28.23
52周最低:9.14
股本:1.03亿
流通股本:7,411.19万
量比:2.15
换手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
净资产收益率:-80.30%
总资产收益率:-40.06%
市净率:5.70
市盈率(LYR):-7.27

数据加载中...

2025/04/08

重要事件披露

Form 8-K - Current report
2025/03/14

SEC问询函

Form CORRESP - Correspondence
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

重要事件披露

Form 8-K - Current report